Toward functional proteomics of alveolar macrophages

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 288, Issue 4 32-4, 2005, Pages

  Wu, Haifeng M ^a   Jin, Ming ^a   Marsh, Clay B ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Chronic obstructive pulmonary disease; Monocytes; Phosphoproteomics; Protein polymorphism; Subproteomics

Indexed keywords

CELL PROTEIN; GENE PRODUCT;

CELL DIFFERENTIATION; CELL FUNCTION; CELL TYPE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE PREDISPOSITION; GENE SEQUENCE; HOMEOSTASIS; HUMAN; INTERMETHOD COMPARISON; LUNG ALVEOLUS MACROPHAGE; LUNG DISEASE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN PHOSPHORYLATION; PROTEIN POLYMORPHISM; PROTEIN PROCESSING; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; SMOKING; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MACROPHAGES, ALVEOLAR; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 15544378960     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00305.2004     Document Type: Review

References (80)

1. Aderem A and Underhill DM. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 17: 593-623, 1999.
2. Arnott D, Gawinowicz MA, Grant RA, Neubert TA, Packman LC, Speicher KD, Stone K, and Turck CW. ABRF-PRG03: phosphorylation site determination. J Biomol Tech 14: 205-215, 2003.
3. Atkinson JJ and Senior RM. Matrix metalloproteinase-9 in lung remodeling. Annu J Respir Cell Mol Biol 28: 12-24, 2003.
4. Beeh KM, Beier J, Kornmann O, and Buhl R. Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects. Respir Med 97: 634-639, 2003.
5. Betsuyaku T, Tanino M, Nagai K, Nasuhara Y, Nishimura M, and Senior RM. Extracellular matrix metalloproteinase inducer is increased in smokers' bronchoalveolar lavage fluid. Am J Respir Crit Care Med 168: 222-227, 2003.
6. Breitschopf K, Haendeler J, Malchow P, Zeiher AM, and Dimmeler S. Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway. Mol Cell Biol 20: 1886-1896, 2000.
7. Brown GP, Iwamoto GK, Monick MM, and Hunninghake GW. Cigarette smoking decreases interleukin 1 release by human alveolar macrophages. Am J Physiol Cell Physiol 256: C260-C264, 1989.
8. Caputo E, Moharram R, and Martin BM. Methods for on-chip protein analysis. Anal Biochem 321: 116-124, 2003.
9. Caveggion E, Continolo S, Pixley FJ, Stanley ER, Bowtell DD, Lowell CA, and Berton G. Expression and tyrosine phosphorylation of Cbl regulates macrophage chemokinetic and chemotactic movement. J Cell Physiol 195: 276-289, 2003.
10. Cawston T, Carrere S, Catterall J, Duggleby R, Elliott S, Shingleton B, and Rowan A. Matrix metalloproteinases and TIMPs: properties and implications for the treatment of chronic obstructive pulmonary disease. Novartis Foundation Symp 234: 205-218; discussion 218-228, 2001.
11. Chapman HA Jr, Munger JS, and Shi GP. The role of thiol proteases in tissue injury and remodeling. Am J Respir Crit Care Med 150: S155-S159, 1994.
12. Churg A, Dai J, Tai H, Xie C, and Wright JL. Tumor necrosis factor-α is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am J Respir Crit Care Med 166: 849-854, 2002.
13. Churg A, Wang RD, Tai H, Wang X, Xie C, Dai J, Shapiro SD, and Wright JL. Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-α release. Am J Respir Crit Care Med 167: 1083-1089, 2003.
14. Clarke W, Zhang Z, and Chan DW. The application of clinical proteomics to cancer and other diseases. Clin Chem Lab Med 41: 1562-1570, 2003.
15. Cohen P. The regulation of protein function by multisite phosphorylation-α 25 year update. Trends Biochem Sci 25: 596-601, 2000.
16. Cosio BG, Mann B, Ito K, Jazrawi E, Barnes PJ, Chung KF, and Adcock IM. Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma. Am J Respir Crit Care Med 170: 141-147, 2004.
17. Culver DA, Barna BP, Raychaudhuri B, Bonfield TL, Abraham S, Malur A, Farver CF, Kavuru MS, and Thomassen MJ. Peroxisome proliferator-activated receptor γ activity is deficient in alveolar macrophages in pulmonary sarcoidosis. Am J Respir Cell Mol Biol 30: 1-5, 2004.
18. Dabiri GA, Young CL, Rosenbloom J, and Southwick FS. Molecular cloning of human macrophage capping protein cDNA. A unique member of the gelsolin/villin family expressed primarily in macrophages. J Biol Chem 267: 16545-16552, 1992.
19. Dorger M and Krombach F. Interaction of alveolar macrophages with inhaled mineral particulates. J Aerosol Med 13: 369-380, 2000.
20. Figeys D. Adapting arrays and lab-on-a-chip technology for proteomics. Proteomics 2: 373-382, 2002.
21. Finkelstein R, Fraser RS, Ghezzo H, and Cosio MG. Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 152: 1666-1672, 1995.
22. Goldsmith CA, Frevert C, Imrich A, Sioutas C, and Kobzik L. Alveolar macrophage interaction with air pollution particulates. Environ Health Perspect 105, Suppl 5: 1191-1195, 1997.
23. Graves PR and Haystead TA. A functional proteomics approach to signal transduction. Recent Prog Horm Res 58: 1-24, 2003.
24. Guttman A, Varoglu M, and Khandurina J. Multidimensional separations in the pharmaceutical arena. Drug Discov Today 9: 136-144, 2004.
25. Hall A. Rho GTPases and the actin cytoskeleton. Science 279: 509-514, 1998.
26. Hanash S. Disease proteomics. Nature 422: 226-232, 2003.
27. Hautamaki RD, Kobayashi DK, Senior RM, and Shapiro SD. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277: 2002-2004, 1997.
28. Hinman LM, Stevens CA, Matthay RA, and Gee JB. Elastase and lysozyme activities in human alveolar macrophages. Effects of cigarette smoking. Am Rev Respir Dis 121: 263-271, 1980.
29. Hirsch J, Hansen KC, Burlingame AL, and Matthay MA. Proteomics: current techniques and potential applications to lung disease. Am J Physiol Lung Cell Mol Physiol 287: L1-L23, 2004.
30. Iles KE and Forman HJ. Macrophage signaling and respiratory burst. Immunol Res 26: 95-105, 2002.
31. Ito K, Lim S, Caramori G, Chung KF, Barnes PJ, and Adcock IM. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J 15: 1110-1112, 2001.
32. Izmirlian G. Application of the random forest classification algorithm to a SELDI-TOF proteomics study in the setting of a cancer prevention trial. Ann NY Acad Sci 1020: 154-174, 2004.
33. 1-antitrypsin deficiency. Lancet 1: 152-154, 1985.
34. Jeffery PK. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax 53: 129-136, 1998.
35. Jin M, Opalek JM, Marsh CB, and Wu HM. Proteome comparison of alveolar macrophages with monocytes reveals distinct protein characteristics. Am J Respir Cell Mol Biol 31: 322-329, 2004.
36. Jones GE. Cellular signaling in macrophage migration and chemotaxis. J Leukoc Biol 68: 593-602, 2000.
37. Kelley TW, Graham MM, Doseff AI, Pomerantz RW, Lau SM, Ostrowski MC, Franke TF, and Marsh CB. Macrophage colony-stimulating factor promotes cell survival through Akt/protein kinase B. J Biol Chem 274: 26393-26398, 1999.
38. Knight ZA, Schilling B, Row RH, Kenski DM, Gibson BW, and Shokat KM. Phosphospecific proteolysis for mapping sites of protein phosphorylation. Nat Biotechnol 21: 1047-1054, 2003.
39. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, Stange-Thomann N, Stojanovic N, Subramanian A, Wyman D, Rogers J, Sulston J, Ainscough R, Beck S, Bentley D, Burton J, Clee C, Carter N, Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R, French L, Grafham D, Gregory S, Hubbard T, Humphrey S, Hunt A, Jones M, Lloyd C, McMurray A, Matthews L, Mercer S, Milne S, Mullikin JC, Mungall A, Plumb R, Ross M, Shownkeen R, Sims S, Waterston RH, Wilson RK, Hillier LW, McPherson JD, Marra MA, Mardis ER, Fulton LA, Chinwalla AT, Pepin KH, Gish WR, Chissoe SL, Wendl MC, Delehaunty KD, Miner TL, Delehaunty A, Kramer JB, Cook LL, Fulton RS, Johnson DL, Minx PJ, Clifton SW, Hawkins T, Branscomb E, Predki P, Richardson P, Wenning S, Slezak T, Doggett N, Cheng JF, Olsen A, Lucas S, Elkin C, Uberbacher E, Frazier M, Gibbs RA, Muzny DM, Scherer SE, Bouck JB, Sodergren EJ, Worley KC, Rives CM, Gorrell JH, Metzker ML, Naylor SL, Kucherlapati RS, Nelson DL, Weinstock GM, Sakaki Y, Fujiyama A, Hattori M, Yada T, Toyoda A, Itoh T, Kawagoe C, Watanabe H, Totoki Y, Taylor T, Weissenbach J, Heilig R, Saurin W, Artiguenave F, Brottier P, Bruls T, Pelletier E, Robert C, Wincker P, Smith DR, Doucette-Stamm L, Rubenfield M, Weinstock K, Lee HM, Dubois J, Rosenthal A, Platzer M, Nyakatura G, Taudien S, Rump A, Yang H, Yu J, Wang J, Huang G, Gu J, Hood L, Rowen L, Madan A, Qin S, Davis RW, Federspiel NA, Abola AP, Proctor MJ, Myers RM, Schmutz J, Dickson M, Grimwood J, Cox DR, Olson MV, Kaul R, Shimizu N, Kawasaki K, Minoshima S, Evans GA, Athanasiou M, Schultz R, Roe BA, Chen F, Pan H, Ramser J, Lehrach H, Reinhardt R, McCombie WR, de la Bastide M, Dedhia N, Blocker H, Hornischer K, Nordsiek G, Agarwala R, Aravind L, Bailey JA, Bateman A, Batzoglou S, Birney E, Bork P, Brown DG, Burge CB, Cerutti L, Chen HC, Church D, Clamp M, Copley RR, Doerks T, Eddy SR, Eichler EE, Furey TS, Galagan J, Gilbert JG, Harmon C, Hayashizaki Y, Haussler D, Hermjakob H, Hokamp K, Jang W, Johnson LS, Jones TA, Kasif S, Kaspryzk A, Kennedy S, Kent WJ, Kitts P, Koonin EV, Korf I, Kulp D, Lancet D, Lowe TM, McLysaght A, Mikkelsen T, Moran JV, Mulder N, Pollara VJ, Ponting CP, Schuler G, Schultz J, Slater G, Smit AF, Stupka E, Szustakowski J, Thierry-Mieg D, Thierry-Mieg J, Wagner L, Wallis J, Wheeler R, Williams A, Wolf YI, Wolfe KH, Yang SP, Yeh RF, Collins F, Guyer MS, Peterson J, Felsenfeld A, Wetterstrand KA, Patrinos A, Morgan MJ, Szustakowki J, de Jong P, Catanese JJ, Osoegawa K, Shizuya H, Choi S, and Chen YJ. Initial sequencing and analysis of the human genome. Nature 409: 860-921, 2001.
40. Li H, Cui D, Tong X, Ma N, Gao Y, Cui X, Lu L, Wang D, and Liang Y. The role of matrix metalloproteinases in extracellular matrix remodelling in chronic obstructive pulmonary disease rat models. Zhonghua Nei Ke Za Zhi 41: 393-398, 2002.
41. Lim S, Roche N, Oliver BG, Mattos W, Barnes PJ, and Fan Chung K. Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10. Am J Respir Crit Care Med 162: 1355-1360, 2000.
42. MacNee W and Rahman I. Is oxidative stress central to the pathogenesis of chronic obstructive pulmonary disease? Trends Mol Med 7: 55-62, 2001.
43. Mann M, Ong SE, Gronborg M, Steen H, Jensen ON, and Pandey A. Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. Trends Biotechnol 20: 261-268, 2002.
44. Marsh CB, Anderson CL, Lowe MP, and Wewers MD. Monocyte IL-8 release is induced by two independent Fc γ R-mediated pathways. J Immunol 157: 2632-2637, 1996.
45. Marsh CB, Wewers MD, Tan LC, and Rovin BH. Fcγ receptor cross-linking induces peripheral blood mononuclear cell monocyte chemoattractant protein-1 expression: role of lymphocyte FcγRIII. J Immunol 158: 1078-1084, 1997.
46. May RC, Caron E, Hall A, and Machesky LM. Involvement of the Arp2/3 complex in phagocytosis mediated by FcγR or CR3. Nat Cell Biol 2: 246-248, 2000.
47. Menard R, Nagler DK, Zhang R, Tam W, Sulea T, and Purisima EO. Human cathepsin X. A novel cysteine protease with unique specificity. Adv Exp Med Biol 477: 317-322, 2000.
48. Moller DR. Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 16: 24-31, 1999.
49. Molloy MP, Brzezinski EE, Hang J, McDowell MT, and VanBogelen RA. Overcoming technical variation and biological variation in quantitative proteomics. Proteomics 3: 1912-1919, 2003.
50. Monick MM and Hunninghake GW. Activation of second messenger pathways in alveolar macrophages by endotoxin. Eur Respir J 20: 210-222, 2002.
51. 6-mediated TGF-β activation causes Mmp12-dependent emphysema. Nature 422: 169-173, 2003.
52. Muley T, Wiebel M, Schulz V, and Ebert W. Elastinolytic activity of alveolar macrophages in smoking-associated pulmonary emphysema. Clin Investig 72: 269-276, 1994.
53. Nakamura H, Fujishima S, Waki Y, Urano T, Sayama K, Sakamaki F, Terashima T, Soejima K, Tasaka S, and Ishizaka A. Priming of alveolar macrophages for interleukin-8 production in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 152: 1579-1586, 1995.
54. Nunoi H, Yamazaki T, Tsuchiya H, Kato S, Malech HL, Matsuda I, and Kanegasaki S. A heterozygous mutation of β-actin associated with neutrophil dysfunction and recurrent infection. Proc Natl Acad Sci USA 96: 8693-8698, 1999.
55. Rao KM. MAP kinase activation in macrophages. J Leukoc Biol 69: 3-10, 2001.
56. Raulo SM, Sorsa T, Tervahartiala T, Pirila E, and Maisi P. MMP-9 as a marker of inflammation in tracheal epithelial lining fluid and in bronchoalveolar fluid of COPD horses. Equine Vet J 33: 128-136, 2001.
57. Repine JE, Bast A, and Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am J Respir Crit Care Med 156: 341-357, 1997.
58. Rossman MD, Maida BT, and Douglas SD. Monocyte-derived macrophage and alveolar macrophage fibronectin production and cathepsin D activity. Cell Immunol 126: 268-277, 1990.
59. Rubins JB. Alveolar macrophages: wielding the double-edged sword of inflammation. Am J Respir Crit Care Med 167: 103-104, 2003.
60. Russell RE, Culpitt SV, DeMatos C, Donnelly L, Smith M, Wiggins J, and Barnes PJ. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 26: 602-609, 2002.
61. Sakai K, Nii Y, Ueyama A, and Kishino Y. Fluorescence demonstration of cathepsin B activity in fractionated alveolar macrophages. Cell Mol Biol 37: 353-358, 1991.
62. Schulenberg B and Patton WF. Combining microscale solution-phase isoelectric focusing with Multiplexed Proteomics dye staining to analyze protein post-translational modifications. Electrophoresis 25: 2539-2544, 2004.
63. Senior RM, Connolly NL, Cury JD, Welgus HG, and Campbell EJ. Elastin degradation by human alveolar macrophages. A prominent role of metalloproteinase activity. Am Rev Respir Dis 139: 1251-1256, 1989.
64. Shapiro SD and Senior RM. Matrix metalloproteinases, matrix degradation and more. Am J Respir Cell Mol Biol 20: 1100-1102, 1999.
65. Soliman DM and Twigg HL III. Cigarette smoking decreases bioactive interleukin-6 secretion by alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 263: L471-L478, 1992.
66. Steinberg TH, Agnew BJ, and Patton WF. Global quantitative phosphoprotein analysis using multiplexed proteomics technology. Proteomics 3: 1128-1144, 2003.
67. Tetley TD. Macrophages and the pathogenesis of COPD. Chest 121: 156S-159S, 2002.
68. Thomassen MJ, Barna BP, Wiedemann HP, Farmer M, and Ahmad M. Human alveolar macrophage function: differences between smokers and nonsmokers. J Leukoc Biol 44: 313-318, 1988.
69. 1 Antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British Thoracic Association. Br J Dis Chest 77: 14-27, 1983.
70. Trapnell BC and Whitsett JA. GM-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu Rev Physiol 64: 775-802, 2002.
71. Tse SM, Furuya W, Gold E, Schreiber AD, Sandvig K, Inman RD, and Grinstein S. Differential role of actin, clathrin, and dynamin in Fc γ receptor-mediated endocytosis and phagocytosis. J Biol Chem 278: 3331-3338, 2003.
72. Valle RP, Jendoubi M, and Figeys D. Antibody-based technologies for target discovery. Adapting arrays and lab-on-a-chip technology for proteomics. Curr Opin Drug Discov Devel 6: 197-203, 2003.
73. Viksman MY, Liu MC, Bickel CA, Schleimer RP, and Bochner BS. Phenotypic analysis of alveolar macrophages and monocytes in allergic airway inflammation. I. Evidence for activation of alveolar macrophages, but not peripheral blood monocytes, in subjects with allergic rhinitis and asthma. Am J Respir Crit Care Med 155: 858-863, 1997.
74. Weiner OD, Servant G, Welch MD, Mitchison TJ, Sedat JW, and Bourne HR. Spatial control of actin polymerization during neutrophil chemotaxis. Nat Cell Biol 1: 75-81, 1999.
75. Wilborn J, Bailie M, Coffey M, Burdick M, Strieter R, and Peters-Golden M. Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest 97: 1827-1836, 1996.
76. Witke W, Li W, Kwiatkowski DJ, and Southwick FS. Comparisons of CapG and gelsolin-null macrophages: demonstration of a unique role for CapG in receptor-mediated ruffling, phagocytosis, and vesicle rocketing. J Cell Biol 154: 775-784, 2001.
77. Wulfkuhle JD, Liotta LA, and Petricoin EF. Proteomic applications for the early detection of cancer. Nat Rev Cancer 3: 267-275, 2003.
78. Yates JR III. Mass spectral analysis in proteomics. Annu Rev Biophys Biomol Struct 33: 297-316, 2004.
79. Yates JR III. Mass spectrometry as an emerging tool for systems biology. Biotechniques 36: 917-919, 2004.
80. Ziegenhagen MW and Muller-Quernheim J. The cytokine network in sarcoidosis and its clinical relevance. J Intern Med 253: 18-30, 2003.